Sign In
Buy BWAY
$14.04
-0.520 (-3.57%)
At Close: Jun 03, 2026
CRESSKILL, N.J. and JERUSALEM, March 01, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of
BrainsWay Ltd. Announces Proposed Public Offering of American Depositary Shares
04:02pm, Monday, 22'nd Feb 2021
CRESSKILL, N.J. and JERUSALEM, Feb. 22, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of
BrainsWay Enhances Commercial Leadership Team with the Addition of Fran Hackett as Vice President of North American Sales
07:30am, Tuesday, 16'th Feb 2021
CRESSKILL, N.J. and JERUSALEM, Israel, Feb. 16, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd . (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive trea
Brainsway: Still Undervalued
01:57pm, Thursday, 24'th Dec 2020
FDA clearance for smoking cessation moves Brainsway towards a portfolio of neurological disorder treatments and extends the company's competitive advantage. The publication of positive real-world resu
Brainsway Ltd. (BWAY) CEO Chris von Jako on Q3 2020 Results - Earnings Call Transcript
12:37pm, Wednesday, 18'th Nov 2020
Brainsway Ltd. (BWAY) CEO Chris von Jako on Q3 2020 Results - Earnings Call Transcript
BrainsWay Hosting Key Opinion Leader Call on Deep Transcranial Magnetic Stimulation for Treating Psychiatric Disorders
07:00am, Tuesday, 17'th Nov 2020
Monday, November 23, 2020, at 10:00 AM Eastern Time Monday, November 23, 2020, at 10:00 AM Eastern Time
BrainsWay to Report Third Quarter 2020 Financial Results and Operational Highlights on November 18, 2020
07:00am, Wednesday, 04'th Nov 2020
CRESSKILL, N.J. and JERUSALEM, Nov. 04, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of b
Brainsway: Lockdowns Are Hiding Progress In The Business
06:30am, Tuesday, 25'th Aug 2020
Brainsway is a technology leader in a relatively new market which has significant potential if it becomes widely accepted by doctors and patients.
Brainsway: Q2 Earnings Insights
11:24am, Wednesday, 12'th Aug 2020
Shares of Brainsway (NASDAQ:BWAY) remained unaffected after the company reported Q2 results.Quarterly Results Earnings per share were up 82.35% over the past year to ($0.03), which beat the estimate o
BrainsWay Reports Second Quarter 2020 Financial Results and Operational Highlights
11:00am, Wednesday, 12'th Aug 2020
CRESSKILL, N.J. and JERUSALEM, Israel, Aug. 12, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treat
BrainsWay to Report Second Quarter 2020 Financial Results and Operational Highlights on August 12, 2020
11:00am, Wednesday, 29'th Jul 2020
CRESSKILL, N.J. and JERUSALEM, Israel, July 29, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatm
PATTERSON, N.J., July 21, 2020 -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain.
BrainsWay Ltd. (BWAY) CEO Christopher von Jako on Q1 2020 Results - Earnings Call Transcript
07:24am, Thursday, 25'th Jun 2020CORRECTION - BrainsWay Reports First Quarter 2020 Financial Results and Operational Highlights
06:09pm, Wednesday, 24'th Jun 2020
PATTERSON, N.J. and JERUSALEM, June 24, 2020 -- In a release issued under the same headline earlier today, June 24th, by BrainsWay Ltd. (NASDAQ & TASE: BWAY), please note.
BrainsWay Reports First Quarter 2020 Financial Results and Operational Highlights
11:30am, Wednesday, 24'th Jun 2020
PATTERSON, N.J. and JERUSALEM, June 24, 2020 -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment.
